SlideShare uma empresa Scribd logo
1 de 21
Corporate Presentation
April 2015
About Safeguard Scientifics (NYSE:SFE)
> Founded in 1953
> NYSE-listed since 1971
> Proven Partner for entrepreneurs looking to accelerate growth and
build long-term value in their businesses
> Industry Focus on healthcare and technology
> Successful Track Record includes $765M realized since 2006
> Deep Domain Expertise as financiers and entrepreneurs
> Strong Balance Sheet and Liquidity
2
Why Own Safeguard (NYSE:SFE)?
> Full Value Yet to be Realized or Recognized
> Ownership Stakes in Exciting Partner Companies
> Top Performance of Proven Team
> Financial Strength, Flexibility and Liquidity
> Strong Alignment of Interests
3
Our Team
4
Capital Deployment Objectives
5
2014 Pipeline Overview
6
Partner Companies By Sector
7
Partner Companies By Revenue Stage
8
Aggregate Partner Company Revenue
9
Partner Company Highlights: Good Start Genetics
10
Partner Company Highlights: MediaMath
11
*Source: eMarketer
Partner Company Highlights: Putney
12
*Source: Packaged Facts, “Pet Medications in the U.S.” (April 2014)
Partner Company Holdings
Acquisition
Year
Primary
Ownership %
Carrying
Value Cost
Healthcare Partner Companies: (in millions) (in millions)
AdvantEdge Healthcare Solutions 2006 40% 5.2$ 15.3$
Dabo Health 2013 15% 2.0 2.0
Good Start Genetics 2010 30% 1.5 12.0
InfoBionic 2014 28% 7.0 8.0
Medivo 2011 35% 6.3 11.6
NovaSom 2011 32% 7.2 21.1
Propeller Health 2014 25% 8.7 9.0
Putney 2011 28% 4.6 14.9
Quantia 2013 42% 9.1 12.5
Syapse 2014 27% 5.5 5.8
Trice Medical 2014 32% 4.6 5.0
TOTAL: 61.7 117.2
Technology Partner Companies:
AppFirst 2012 34% 4.8 8.6
Apprenda 2013 22% 9.7 12.1
Beyond.com 2007 38% 10.2 13.5
Bridgevine 2007 17% 4.6 10.0
Clutch 2013 30% 5.7 7.5
DriveFactor 2011 41% 2.9 4.5
Hoopla Software 2011 26% 1.0 3.1
Lumesis 2012 46% 3.0 5.6
MediaMath 2009 21% 18.6 25.5
Pneuron 2013 28% 4.1 5.0
Spongecell 2012 23% 8.5 10.0
Transactis 2014 25% 9.2 9.5
WebLinc 2014 29% 5.8 6.0
TOTAL: 88.1 120.9
Total: Healthcare + Technology 149.8$ 238.1$
13
Success Stories
14
2014 Cash Flow
Beginning cash at 1/1/14 183.7$
Sources:
Exit proceeds 81.3
Proceeds from mezzanine interests 6.0
Other 2.7
Total Sources 90.0
Uses:
New partner company deployments 43.3
Follow-on funding 26.6
SFE stock buyback 25.0
Corporate expenses - cash paid 17.5
Interest, net 2.9
Other 1.9
Total Uses 117.2
Ending cash at 12/31/14 156.5$
15
(in millions)
NOLs and Capital Loss Carryforwards
16
Equity Incentive Compensation
> Key Goals
• Structured to align with shareholder interest
• Consistent with carried interest methodology
• Majority of vesting based on performance criteria
> Performance Vesting
• Upon achievement of cash-on-cash return thresholds (2.0x-3.0x) on pools of capital
deployed
> Insider Ownership
• 39% of outstanding grants are vested
• Ownership requirements of 2x-4x base salary for senior management
17
2014 Report Card
18
2015 Goals and Objectives
> Increase total number of partner companies to approximately 30
> Realize continued growth in partner company aggregate revenue
> Deploy $35M - $50M in new partner companies
> Deploy $30M - $50M in follow-on funding for current partner companies
> Realize a minimum of two profitable exits
19
John E. Shave III
SENIOR VICE PRESIDENT,
INVESTOR RELATIONS &
CORPORATE COMMUNICATIONS
P 610.975.4952
E jshave@safeguard.com
Request a Meeting:
www.safeguard.com/RequestAMeeting
20
Forward Looking Statements
Statements contained in this presentation that are not historical facts are forward looking
statements which involve certain risks and uncertainties including, but not limited to, risks
associated with our ability to make good decisions about the deployment of capital, the fact
that our partner companies may vary from period to period, our substantial capital
requirements and absence of liquidity from our partner company holdings, fluctuations in
the market prices of our publicly traded partner company holdings, competition, our
inability to obtain maximum value for our partner company holdings, our ability to attract
and retain qualified employees, market valuations in sectors in which our partner
companies operate may decline, our inability to control our partner companies, our need to
manage our assets to avoid registration under the Investment Company Act of 1940, and
risks associated with our partner companies, and other uncertainties as described in our
filings with the Securities and Exchange Commission, including our Annual Report on Form
10-K. Many of these factors are beyond our ability to predict or control. As a result of these
and other factors, our past financial performance should not be relied on as an indication
of future performance.
Safeguard does not assume any obligation to update any forward looking statements or
other information contained in this presentation. predicted or controlled. You should not
rely on these statements as indicative of the partner company’s future results, and all
forward looking statements are qualified by this cautionary statement. All information is as
of the date indicated or as of the date of this presentation, and none of the partner
companies assumes any obligation to update or revise the information presented.
21

Mais conteúdo relacionado

Mais procurados

Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012Safeguard Scientifics
 
10.25.12 sfe q3 2012 results presentation final
10.25.12 sfe q3 2012 results   presentation final10.25.12 sfe q3 2012 results   presentation final
10.25.12 sfe q3 2012 results presentation finalSafeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...Safeguard Scientifics
 
Orchard presentation gbp a class - feb 15 - dominic
Orchard presentation   gbp a class - feb 15 - dominicOrchard presentation   gbp a class - feb 15 - dominic
Orchard presentation gbp a class - feb 15 - dominicDominic Hardcastle
 
2016년 2분기 ir 자료 캐피탈en
2016년 2분기 ir 자료 캐피탈en2016년 2분기 ir 자료 캐피탈en
2016년 2분기 ir 자료 캐피탈enHyundai Finance
 
AlphaClone Active Indexing
AlphaClone Active IndexingAlphaClone Active Indexing
AlphaClone Active IndexingAlphaClone, Inc.
 
Sales Compensation in SaaS Companies Annual Survey 2018
Sales Compensation in SaaS Companies Annual Survey 2018Sales Compensation in SaaS Companies Annual Survey 2018
Sales Compensation in SaaS Companies Annual Survey 2018Viola Group
 
VEREIT: Between A Rock And A Hard Place? - Featured on Seeking Alpha
VEREIT: Between A Rock And A Hard Place? - Featured on Seeking Alpha VEREIT: Between A Rock And A Hard Place? - Featured on Seeking Alpha
VEREIT: Between A Rock And A Hard Place? - Featured on Seeking Alpha Stanley Laman Group Ltd
 
Annual General and Special meeting Jan 2018
Annual General and Special meeting Jan 2018Annual General and Special meeting Jan 2018
Annual General and Special meeting Jan 2018EXFO Inc.
 
Carfinco Corporate Presentation 13
Carfinco Corporate Presentation 13Carfinco Corporate Presentation 13
Carfinco Corporate Presentation 13Company Spotlight
 
806920110728
806920110728806920110728
806920110728yo9889
 
Evaluation of Investment in Billabong International limited.
Evaluation of Investment in Billabong International limited.Evaluation of Investment in Billabong International limited.
Evaluation of Investment in Billabong International limited.MyAssignmenthelp.com
 
1Q09 Results Conference Call
1Q09 Results Conference Call1Q09 Results Conference Call
1Q09 Results Conference CallKianne Paganini
 

Mais procurados (20)

Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - October 2012
 
10.25.12 sfe q3 2012 results presentation final
10.25.12 sfe q3 2012 results   presentation final10.25.12 sfe q3 2012 results   presentation final
10.25.12 sfe q3 2012 results presentation final
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
 
Law Debenture Corp
Law Debenture CorpLaw Debenture Corp
Law Debenture Corp
 
Orchard presentation gbp a class - feb 15 - dominic
Orchard presentation   gbp a class - feb 15 - dominicOrchard presentation   gbp a class - feb 15 - dominic
Orchard presentation gbp a class - feb 15 - dominic
 
2016년 2분기 ir 자료 캐피탈en
2016년 2분기 ir 자료 캐피탈en2016년 2분기 ir 자료 캐피탈en
2016년 2분기 ir 자료 캐피탈en
 
Shabir-Compliance
Shabir-ComplianceShabir-Compliance
Shabir-Compliance
 
AlphaClone Active Indexing
AlphaClone Active IndexingAlphaClone Active Indexing
AlphaClone Active Indexing
 
Chanakya
ChanakyaChanakya
Chanakya
 
Sales Compensation in SaaS Companies Annual Survey 2018
Sales Compensation in SaaS Companies Annual Survey 2018Sales Compensation in SaaS Companies Annual Survey 2018
Sales Compensation in SaaS Companies Annual Survey 2018
 
VEREIT: Between A Rock And A Hard Place? - Featured on Seeking Alpha
VEREIT: Between A Rock And A Hard Place? - Featured on Seeking Alpha VEREIT: Between A Rock And A Hard Place? - Featured on Seeking Alpha
VEREIT: Between A Rock And A Hard Place? - Featured on Seeking Alpha
 
8 i holding ppt
8 i holding ppt8 i holding ppt
8 i holding ppt
 
Singapore IRAS PIC Grants
Singapore IRAS PIC GrantsSingapore IRAS PIC Grants
Singapore IRAS PIC Grants
 
Annual General and Special meeting Jan 2018
Annual General and Special meeting Jan 2018Annual General and Special meeting Jan 2018
Annual General and Special meeting Jan 2018
 
Carfinco Corporate Presentation 13
Carfinco Corporate Presentation 13Carfinco Corporate Presentation 13
Carfinco Corporate Presentation 13
 
806920110728
806920110728806920110728
806920110728
 
Trends in Fund Upstarts
Trends in Fund UpstartsTrends in Fund Upstarts
Trends in Fund Upstarts
 
Evaluation of Investment in Billabong International limited.
Evaluation of Investment in Billabong International limited.Evaluation of Investment in Billabong International limited.
Evaluation of Investment in Billabong International limited.
 
1Q09 Results Conference Call
1Q09 Results Conference Call1Q09 Results Conference Call
1Q09 Results Conference Call
 
Sources of Funding of Dabur
Sources of Funding of DaburSources of Funding of Dabur
Sources of Funding of Dabur
 

Destaque

Syapse Presentation at Health2.0 Silicon Valley meetup 7-16-13
Syapse Presentation at Health2.0 Silicon Valley meetup 7-16-13Syapse Presentation at Health2.0 Silicon Valley meetup 7-16-13
Syapse Presentation at Health2.0 Silicon Valley meetup 7-16-13David Parpart, D.C.
 
Turning Big Data into Precision Medicine
Turning Big Data into Precision MedicineTurning Big Data into Precision Medicine
Turning Big Data into Precision MedicineMatthieu Schapranow
 
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...University of California, San Francisco
 
(HLS305) Transforming Cancer Treatment: Integrating Data to Deliver on the Pr...
(HLS305) Transforming Cancer Treatment: Integrating Data to Deliver on the Pr...(HLS305) Transforming Cancer Treatment: Integrating Data to Deliver on the Pr...
(HLS305) Transforming Cancer Treatment: Integrating Data to Deliver on the Pr...Amazon Web Services
 
Electronic Medical Records: From Clinical Decision Support to Precision Medicine
Electronic Medical Records: From Clinical Decision Support to Precision MedicineElectronic Medical Records: From Clinical Decision Support to Precision Medicine
Electronic Medical Records: From Clinical Decision Support to Precision MedicineKent State University
 
Potential partner pitch
Potential partner pitchPotential partner pitch
Potential partner pitchJan Bendtsen
 
Partnership Proposal
Partnership ProposalPartnership Proposal
Partnership ProposalArvind Jha
 
Partnership presentation
Partnership presentationPartnership presentation
Partnership presentationemail2neev
 
Dwolla Startup Pitch Deck
Dwolla Startup Pitch DeckDwolla Startup Pitch Deck
Dwolla Startup Pitch DeckJoseph Hsieh
 
Linkedin Series B Pitch Deck
Linkedin Series B Pitch DeckLinkedin Series B Pitch Deck
Linkedin Series B Pitch DeckJoseph Hsieh
 
Mixpanel - Our pitch deck that we used to raise $65M
Mixpanel - Our pitch deck that we used to raise $65MMixpanel - Our pitch deck that we used to raise $65M
Mixpanel - Our pitch deck that we used to raise $65MSuhail Doshi
 
The slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollarsThe slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollarsBuffer
 

Destaque (14)

Syapse Presentation at Health2.0 Silicon Valley meetup 7-16-13
Syapse Presentation at Health2.0 Silicon Valley meetup 7-16-13Syapse Presentation at Health2.0 Silicon Valley meetup 7-16-13
Syapse Presentation at Health2.0 Silicon Valley meetup 7-16-13
 
VCF and RDF
VCF and RDFVCF and RDF
VCF and RDF
 
Turning Big Data into Precision Medicine
Turning Big Data into Precision MedicineTurning Big Data into Precision Medicine
Turning Big Data into Precision Medicine
 
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
2015-04-28 Atul Butte's presentation to the NIH Precision Medicine Initiative...
 
(HLS305) Transforming Cancer Treatment: Integrating Data to Deliver on the Pr...
(HLS305) Transforming Cancer Treatment: Integrating Data to Deliver on the Pr...(HLS305) Transforming Cancer Treatment: Integrating Data to Deliver on the Pr...
(HLS305) Transforming Cancer Treatment: Integrating Data to Deliver on the Pr...
 
Electronic Medical Records: From Clinical Decision Support to Precision Medicine
Electronic Medical Records: From Clinical Decision Support to Precision MedicineElectronic Medical Records: From Clinical Decision Support to Precision Medicine
Electronic Medical Records: From Clinical Decision Support to Precision Medicine
 
Precision Medicine World Conference 2017
Precision Medicine World Conference 2017Precision Medicine World Conference 2017
Precision Medicine World Conference 2017
 
Potential partner pitch
Potential partner pitchPotential partner pitch
Potential partner pitch
 
Partnership Proposal
Partnership ProposalPartnership Proposal
Partnership Proposal
 
Partnership presentation
Partnership presentationPartnership presentation
Partnership presentation
 
Dwolla Startup Pitch Deck
Dwolla Startup Pitch DeckDwolla Startup Pitch Deck
Dwolla Startup Pitch Deck
 
Linkedin Series B Pitch Deck
Linkedin Series B Pitch DeckLinkedin Series B Pitch Deck
Linkedin Series B Pitch Deck
 
Mixpanel - Our pitch deck that we used to raise $65M
Mixpanel - Our pitch deck that we used to raise $65MMixpanel - Our pitch deck that we used to raise $65M
Mixpanel - Our pitch deck that we used to raise $65M
 
The slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollarsThe slide deck we used to raise half a million dollars
The slide deck we used to raise half a million dollars
 

Semelhante a Safeguard Scientifics Corporate Presentation - April 2015

Safeguard Scientifics Corporate Presentation - April 24, 2015
Safeguard Scientifics Corporate Presentation - April 24, 2015Safeguard Scientifics Corporate Presentation - April 24, 2015
Safeguard Scientifics Corporate Presentation - April 24, 2015Safeguard Scientifics
 
Safeguard Scientifics Corporate Presentation - January 2015
Safeguard Scientifics Corporate Presentation - January 2015Safeguard Scientifics Corporate Presentation - January 2015
Safeguard Scientifics Corporate Presentation - January 2015Safeguard Scientifics
 
Corporate Presentation - December 2014
Corporate Presentation - December 2014Corporate Presentation - December 2014
Corporate Presentation - December 2014Safeguard Scientifics
 
Investor Presentation March 20, 2014
Investor Presentation March 20, 2014Investor Presentation March 20, 2014
Investor Presentation March 20, 2014FinningInternational
 
First Quarter 2014 Earnings Call Presentation - Principal Financial Group
First Quarter 2014 Earnings Call Presentation - Principal Financial GroupFirst Quarter 2014 Earnings Call Presentation - Principal Financial Group
First Quarter 2014 Earnings Call Presentation - Principal Financial Groupinvestors_principalfinancial
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...Safeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012Safeguard Scientifics
 
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014Safeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...Safeguard Scientifics
 
Investor Presentation - Los Angeles, San Francisco
Investor Presentation - Los Angeles, San FranciscoInvestor Presentation - Los Angeles, San Francisco
Investor Presentation - Los Angeles, San FranciscoFinningInternational
 

Semelhante a Safeguard Scientifics Corporate Presentation - April 2015 (20)

Safeguard Scientifics Corporate Presentation - April 24, 2015
Safeguard Scientifics Corporate Presentation - April 24, 2015Safeguard Scientifics Corporate Presentation - April 24, 2015
Safeguard Scientifics Corporate Presentation - April 24, 2015
 
Safeguard Scientifics Corporate Presentation - January 2015
Safeguard Scientifics Corporate Presentation - January 2015Safeguard Scientifics Corporate Presentation - January 2015
Safeguard Scientifics Corporate Presentation - January 2015
 
Corporate Presentation - December 2014
Corporate Presentation - December 2014Corporate Presentation - December 2014
Corporate Presentation - December 2014
 
3Q 2014 Earnings Conference Call Presentation
3Q 2014 Earnings Conference Call Presentation3Q 2014 Earnings Conference Call Presentation
3Q 2014 Earnings Conference Call Presentation
 
3 q14 earnings-call-presentation
3 q14 earnings-call-presentation3 q14 earnings-call-presentation
3 q14 earnings-call-presentation
 
Investor Presentation March 20, 2014
Investor Presentation March 20, 2014Investor Presentation March 20, 2014
Investor Presentation March 20, 2014
 
Aimia's Q4 and full year 2014 results
 Aimia's Q4 and full year 2014 results Aimia's Q4 and full year 2014 results
Aimia's Q4 and full year 2014 results
 
4Q 2014 Earnings Conference Call Presentation
4Q 2014 Earnings Conference Call Presentation4Q 2014 Earnings Conference Call Presentation
4Q 2014 Earnings Conference Call Presentation
 
First Quarter 2014 Earnings Call Presentation - Principal Financial Group
First Quarter 2014 Earnings Call Presentation - Principal Financial GroupFirst Quarter 2014 Earnings Call Presentation - Principal Financial Group
First Quarter 2014 Earnings Call Presentation - Principal Financial Group
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - December ...
 
Investor Day 2013: Aeroplan 2.0
Investor Day 2013: Aeroplan 2.0Investor Day 2013: Aeroplan 2.0
Investor Day 2013: Aeroplan 2.0
 
Investor Day 2013: Aeroplan 2.0
Investor Day 2013: Aeroplan 2.0Investor Day 2013: Aeroplan 2.0
Investor Day 2013: Aeroplan 2.0
 
1Q 2015 Earnings Conference Call Presentation
1Q 2015 Earnings Conference Call Presentation1Q 2015 Earnings Conference Call Presentation
1Q 2015 Earnings Conference Call Presentation
 
First Quarter 2015 Earnings Call Presentation
First Quarter 2015 Earnings Call PresentationFirst Quarter 2015 Earnings Call Presentation
First Quarter 2015 Earnings Call Presentation
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - March 2012
 
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
Safeguard Scientifics (NYSE:SFE) Corporate Presentation - June 2014
 
Investor Day 2013: Coalitions in EMEA
Investor Day 2013: Coalitions in EMEAInvestor Day 2013: Coalitions in EMEA
Investor Day 2013: Coalitions in EMEA
 
Investor Day 2013: Coalitions in EMEA
Investor Day 2013: Coalitions in EMEAInvestor Day 2013: Coalitions in EMEA
Investor Day 2013: Coalitions in EMEA
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - February ...
 
Investor Presentation - Los Angeles, San Francisco
Investor Presentation - Los Angeles, San FranciscoInvestor Presentation - Los Angeles, San Francisco
Investor Presentation - Los Angeles, San Francisco
 

Mais de Safeguard Scientifics

Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...Safeguard Scientifics
 
Anatomy of a Deal: Avid Radiopharmaceuticals
Anatomy of a Deal: Avid RadiopharmaceuticalsAnatomy of a Deal: Avid Radiopharmaceuticals
Anatomy of a Deal: Avid RadiopharmaceuticalsSafeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - September...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - September...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - September...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - September...Safeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - August 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - August 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - August 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - August 2012Safeguard Scientifics
 
Safeguard Scientifics Second Quarter 2012 Financial Results Presentation
Safeguard Scientifics Second Quarter 2012 Financial Results PresentationSafeguard Scientifics Second Quarter 2012 Financial Results Presentation
Safeguard Scientifics Second Quarter 2012 Financial Results PresentationSafeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012Safeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012Safeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - May 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - May 2012 Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - May 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - May 2012 Safeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - April 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - April 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - April 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - April 2012Safeguard Scientifics
 
Safeguard Scientifics Q4 and FY'11 Results Presentation
Safeguard Scientifics Q4 and FY'11 Results PresentationSafeguard Scientifics Q4 and FY'11 Results Presentation
Safeguard Scientifics Q4 and FY'11 Results PresentationSafeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012Safeguard Scientifics
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012Safeguard Scientifics
 

Mais de Safeguard Scientifics (12)

Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - November ...
 
Anatomy of a Deal: Avid Radiopharmaceuticals
Anatomy of a Deal: Avid RadiopharmaceuticalsAnatomy of a Deal: Avid Radiopharmaceuticals
Anatomy of a Deal: Avid Radiopharmaceuticals
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - September...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - September...Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - September...
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - September...
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - August 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - August 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - August 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - August 2012
 
Safeguard Scientifics Second Quarter 2012 Financial Results Presentation
Safeguard Scientifics Second Quarter 2012 Financial Results PresentationSafeguard Scientifics Second Quarter 2012 Financial Results Presentation
Safeguard Scientifics Second Quarter 2012 Financial Results Presentation
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - July 2012
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - June 2012
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - May 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - May 2012 Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - May 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - May 2012
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - April 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - April 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - April 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - April 2012
 
Safeguard Scientifics Q4 and FY'11 Results Presentation
Safeguard Scientifics Q4 and FY'11 Results PresentationSafeguard Scientifics Q4 and FY'11 Results Presentation
Safeguard Scientifics Q4 and FY'11 Results Presentation
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
 
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
Safeguard Scientifics (NYSE: SFE) Investor Relations Presentation - January 2012
 

Safeguard Scientifics Corporate Presentation - April 2015

  • 2. About Safeguard Scientifics (NYSE:SFE) > Founded in 1953 > NYSE-listed since 1971 > Proven Partner for entrepreneurs looking to accelerate growth and build long-term value in their businesses > Industry Focus on healthcare and technology > Successful Track Record includes $765M realized since 2006 > Deep Domain Expertise as financiers and entrepreneurs > Strong Balance Sheet and Liquidity 2
  • 3. Why Own Safeguard (NYSE:SFE)? > Full Value Yet to be Realized or Recognized > Ownership Stakes in Exciting Partner Companies > Top Performance of Proven Team > Financial Strength, Flexibility and Liquidity > Strong Alignment of Interests 3
  • 8. Partner Companies By Revenue Stage 8
  • 10. Partner Company Highlights: Good Start Genetics 10
  • 11. Partner Company Highlights: MediaMath 11 *Source: eMarketer
  • 12. Partner Company Highlights: Putney 12 *Source: Packaged Facts, “Pet Medications in the U.S.” (April 2014)
  • 13. Partner Company Holdings Acquisition Year Primary Ownership % Carrying Value Cost Healthcare Partner Companies: (in millions) (in millions) AdvantEdge Healthcare Solutions 2006 40% 5.2$ 15.3$ Dabo Health 2013 15% 2.0 2.0 Good Start Genetics 2010 30% 1.5 12.0 InfoBionic 2014 28% 7.0 8.0 Medivo 2011 35% 6.3 11.6 NovaSom 2011 32% 7.2 21.1 Propeller Health 2014 25% 8.7 9.0 Putney 2011 28% 4.6 14.9 Quantia 2013 42% 9.1 12.5 Syapse 2014 27% 5.5 5.8 Trice Medical 2014 32% 4.6 5.0 TOTAL: 61.7 117.2 Technology Partner Companies: AppFirst 2012 34% 4.8 8.6 Apprenda 2013 22% 9.7 12.1 Beyond.com 2007 38% 10.2 13.5 Bridgevine 2007 17% 4.6 10.0 Clutch 2013 30% 5.7 7.5 DriveFactor 2011 41% 2.9 4.5 Hoopla Software 2011 26% 1.0 3.1 Lumesis 2012 46% 3.0 5.6 MediaMath 2009 21% 18.6 25.5 Pneuron 2013 28% 4.1 5.0 Spongecell 2012 23% 8.5 10.0 Transactis 2014 25% 9.2 9.5 WebLinc 2014 29% 5.8 6.0 TOTAL: 88.1 120.9 Total: Healthcare + Technology 149.8$ 238.1$ 13
  • 15. 2014 Cash Flow Beginning cash at 1/1/14 183.7$ Sources: Exit proceeds 81.3 Proceeds from mezzanine interests 6.0 Other 2.7 Total Sources 90.0 Uses: New partner company deployments 43.3 Follow-on funding 26.6 SFE stock buyback 25.0 Corporate expenses - cash paid 17.5 Interest, net 2.9 Other 1.9 Total Uses 117.2 Ending cash at 12/31/14 156.5$ 15 (in millions)
  • 16. NOLs and Capital Loss Carryforwards 16
  • 17. Equity Incentive Compensation > Key Goals • Structured to align with shareholder interest • Consistent with carried interest methodology • Majority of vesting based on performance criteria > Performance Vesting • Upon achievement of cash-on-cash return thresholds (2.0x-3.0x) on pools of capital deployed > Insider Ownership • 39% of outstanding grants are vested • Ownership requirements of 2x-4x base salary for senior management 17
  • 19. 2015 Goals and Objectives > Increase total number of partner companies to approximately 30 > Realize continued growth in partner company aggregate revenue > Deploy $35M - $50M in new partner companies > Deploy $30M - $50M in follow-on funding for current partner companies > Realize a minimum of two profitable exits 19
  • 20. John E. Shave III SENIOR VICE PRESIDENT, INVESTOR RELATIONS & CORPORATE COMMUNICATIONS P 610.975.4952 E jshave@safeguard.com Request a Meeting: www.safeguard.com/RequestAMeeting 20
  • 21. Forward Looking Statements Statements contained in this presentation that are not historical facts are forward looking statements which involve certain risks and uncertainties including, but not limited to, risks associated with our ability to make good decisions about the deployment of capital, the fact that our partner companies may vary from period to period, our substantial capital requirements and absence of liquidity from our partner company holdings, fluctuations in the market prices of our publicly traded partner company holdings, competition, our inability to obtain maximum value for our partner company holdings, our ability to attract and retain qualified employees, market valuations in sectors in which our partner companies operate may decline, our inability to control our partner companies, our need to manage our assets to avoid registration under the Investment Company Act of 1940, and risks associated with our partner companies, and other uncertainties as described in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K. Many of these factors are beyond our ability to predict or control. As a result of these and other factors, our past financial performance should not be relied on as an indication of future performance. Safeguard does not assume any obligation to update any forward looking statements or other information contained in this presentation. predicted or controlled. You should not rely on these statements as indicative of the partner company’s future results, and all forward looking statements are qualified by this cautionary statement. All information is as of the date indicated or as of the date of this presentation, and none of the partner companies assumes any obligation to update or revise the information presented. 21